Koji Teramoto

1.4k total citations
81 papers, 1.1k citations indexed

About

Koji Teramoto is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Koji Teramoto has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 23 papers in Immunology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Koji Teramoto's work include Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (13 papers) and vaccines and immunoinformatics approaches (7 papers). Koji Teramoto is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (13 papers) and vaccines and immunoinformatics approaches (7 papers). Koji Teramoto collaborates with scholars based in Japan, United States and Singapore. Koji Teramoto's co-authors include Yataro Daigo, Jun Hanaoka, Hidetoshi Sumimoto, Keiichi Kontani, Atsushi Takano, Tomoyuki Igarashi, Noriaki Tezuka, Mitsuaki Ishida, Yasuhiko Ohshio and Hidetoshi Okabe and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Koji Teramoto

72 papers receiving 1.1k citations

Peers

Countries citing papers authored by Koji Teramoto

Since Specialization

Citations

This map shows the geographic impact of Koji Teramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Teramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Teramoto more than expected).

Fields of papers citing papers by Koji Teramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Teramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Teramoto. The network helps show where Koji Teramoto may publish in the future.

Co-authorship network of co-authors of Koji Teramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Teramoto. A scholar is included among the top collaborators of Koji Teramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Teramoto. Koji Teramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer 2023 ·Cancer Immunology Immunotherapy ·Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka, Mitsuaki Ishida, Jun Hanaoka, Hidetoshi Sumimoto, Yataro Daigo	7
2	Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11) 2020 ·Cellular Signalling ·(unknown), Koji Teramoto, Hironori Katoh	17
3	Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer 2019 ·Lung Cancer ·Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka, Mitsuaki Ishida, Jun Hanaoka, Hidetoshi Sumimoto, Yataro Daigo	49
4	Clinical outcome of posterior fixation surgery in patients with vertebral metastasis of lung cancer 2017 ·Molecular and Clinical Oncology ·Tomoyuki Igarashi, Keigo Okamoto, Koji Teramoto, (unknown), Keiko Ishida, Keiko Ueda, Yo Kawaguchi, Tetsuo Hori, Masayuki Hashimoto, Shōji Kitamura, Noriaki Tezuka, Jun Hanaoka	2
5	RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers 2016 ·PLoS ONE ·Hidetoshi Sumimoto, Atsushi Takano, Koji Teramoto, Yataro Daigo	142
6	Pulmonary metastasis of invasive thymoma, showing endobronchial polypoid growth: report of a case 2013 ·Surgery Today ·Yo Kawaguchi, Jun Hanaoka, Koji Teramoto, Shōji Kitamura, Masayuki Hashimoto, (unknown), Keiko Ishida, A. Shoji	3
7	Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy 2013 ·Journal of Cancer Research and Clinical Oncology ·Koji Teramoto, Yasuhiko Ohshio, Takuya Fujita, Jun Hanaoka, Keiichi Kontani	12
8	A rare case of simultaneous bilateral pneumothorax caused by multiple pulmonary metastases of a femoral giant cell tumor 2012 ·The Journal of the Japanese Association for Chest Surgery ·Masayuki Hashimoto, (unknown), Shōji Kitamura, Koji Teramoto, Jun Hanaoka, Noriaki Tezuka	1
9	A SUCCESSFUL CASE OF AN OPERATION PERFORMED TO CLOSE A PULMONARY FISTULAE UNDER PCPS SUPPORT FOR SIMULTANEOUS BILATERAL PNEUMOTHORAX 2011 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Masayuki Hashimoto, (unknown), Koji Teramoto	0
10	RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients 2010 ·PLoS ONE ·Tokuhiro Chano, (unknown), Yasuhiko Tomita, (unknown), Hideo Inaji, Makoto Ishitobi, Koji Teramoto, (unknown), (unknown), Ichiro Nishimura, Kahori Minami, Hirokazu Inoue, Takahiro Isono, Masao Saitoh, Taketoshi Shimada, Yasuo Hisa, Hidetoshi Okabe	19
11	Inhibition of Transforming Growth Factor-β–Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types 2009 ·Cancer Research ·Takuya Fujita, Koji Teramoto, Yoshitomo Ozaki, Jun Hanaoka, Noriaki Tezuka, Yasushi Itoh, Tohru Asai, Shozo Fujino, Keiichi Kontani, Kazumasa Ogasawara	29
12	Intrathoracic multiple schwannomas originating from a single intercostal nerve: Report of a case and review of the literature 2007 ·The Journal of the Japanese Association for Chest Surgery ·Koji Teramoto, (unknown)	0
13	Good Syndrome Coexisting With Leukopenia 2007 ·The Annals of Thoracic Surgery ·(unknown), Shuhei Inoue, Jun Hanaoka, Tomoyuki Igarashi, Noriaki Tezuka, Yoshitomo Ozaki, Koji Teramoto	16
14	Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA 2006 ·Cancer Immunology Immunotherapy ·Koji Teramoto, Keiichi Kontani, Takuya Fujita, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Shozo Fujino, Yasushi Itoh, Osamu Taguchi, Reiji Kannagi, Kazumasa Ogasawara	11
15	A Case of Metastatic Lung Tumor of Uterine Leiomyosarcoma. 2001 ·Haigan ·Koji Teramoto, Naoki Yamashita, Masayoshi Kuwabara, Takafumi Matsui, Yoshito Matsubara	0
16	Hiccups Induced by Systemic Chemotherapy for Lung Cancer. 2001 ·Haigan ·Koji Teramoto, Masayoshi Kuwabara, Yoshito Matsubara	2
17	Pulmonary veno‐occlusive disease in pulmonary Langerhans′ cell granulomatosis 2000 ·European Respiratory Journal ·(unknown), S Teramoto, (unknown), Eiji Yamada, Koji Teramoto, Lester Kobzik	34
18	A Case of Endobronchial Leiomyoma Resected by Transbronchial Endoscopic Electrosurgery 2000 ·Yoshitomo Ozaki, Masayoshi Kuwabara, Takafumi Matsui, Toshihiko Satō, Koji Teramoto, Shotaro Iwakiri, (unknown), Kazumi Iseki, Hisashi Sahara, (unknown), (unknown), Naoki Yamashita, Yoshito Matsubara	0
19	Absorption, distribution and elimination of styrene in man and experimental animals 1979 ·Archives of Industrial Hygiene and Toxicology ·Koji Teramoto, Shun'ichi Horiguchi	8
20	A long-term health examination upon lead arsenate workers in an insecticides factory. (Studies on lead arsenate poisoning, Part 2). 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Shun'ichi Horiguchi, (unknown), (unknown), Koji Teramoto, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact